On the morning of June 11th, Taisho Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Taisho Pharmaceutical Group"), one of Top 50 pharmaceutical companies in the world, held a signing ceremony with Huangpu District and Minhang District at Hengshan Hotel, Shanghai, which witnessed that China Biopharmaceutical China Headquarters and Taisho Tianqing Global R&D Headquarters and China Biopharmaceutical Shanghai R&D Center officially settled in Shanghai. Wu Qing, Member of the Standing Committee of CPC Shanghai Municipal Committee and Deputy Mayor of Shanghai Municipal Government, Chen Mingbo, Deputy Secretary-General of Shanghai Municipal Government, Wu Jincheng, Chairman of Shanghai Municipal Commission of Economy and Informatization, Li Hong, Second-Level Inspector of Shanghai Municipal Commission of Commerce, Gao Yun, Secretary of CPC Huangpu District Committee, Chen Yujian, Deputy Secretary of CPC Minhang District Committee and Governor of Minhang District, Guan Xiaojun, Member of the Standing Committee of CPC Minhang District Committee and Deputy Governor of Minhang District, Wang Nai, Deputy Governor of Huangpu District, Xie Bing, Chairman of Taisho Pharmaceutical Group, Zheng Xiangling, President of Taisho Pharmaceutical Group, Xie Chengrun, Executive Director of China Biopharmaceutical Co., Ltd. and others attended the signing ceremony, which was presided over by Liu Ping, Deputy Chairmen of Shanghai Municipal Commission of Economy and Informatization.
